Edition:
United Kingdom

Bausch Health Companies Inc (BHC.TO)

BHC.TO on Toronto Stock Exchange

28.26CAD
16 Aug 2019
Change (% chg)

$0.47 (+1.69%)
Prev Close
$27.79
Open
$28.16
Day's High
$28.52
Day's Low
$27.85
Volume
524,230
Avg. Vol
715,025
52-wk High
$36.52
52-wk Low
$23.60

Select another date:

Thu, Apr 25 2019

Bausch Health's lotion for plaque psoriasis wins FDA approval

The U.S. Food and Drug Administration on Thursday approved Bausch Health Companies Inc's topical plaque psoriasis treatment, which is expected to be a key revenue driver for the company.

UPDATE 1-Bausch Health's lotion for plaque psoriasis wins FDA approval

April 25 The U.S. Food and Drug Administration on Thursday approved Bausch Health Companies Inc's topical plaque psoriasis treatment, which is expected to be a key revenue driver for the company.

Bausch Health's lotion for plaque psoriasis wins FDA approval

April 25 Bausch Health Companies Inc said on Thursday the U.S. Food and Drug Administration has approved its lotion for plaque psoriasis in adults.

Select another date: